A 0 1 0 1 O
female 2 8 2 8 B-gender
of 9 11 9 11 O
childbearing 12 24 12 24 O
potential 25 34 25 34 O
is 35 37 35 37 O
a 38 39 38 39 O
sexually 40 48 40 48 O
mature 49 55 49 55 O
woman 56 61 56 61 B-gender
who 62 65 62 65 O
: 65 66 65 66 O
1 67 68 67 68 O
) 68 69 68 69 O
has 70 73 70 73 O
not 74 77 74 77 O
undergone 78 87 78 87 O
a 88 89 88 89 O
hysterectomy 90 102 90 102 B-treatment
or 103 105 103 105 O
bilateral 106 115 106 115 B-treatment
oophorectomy 116 128 116 128 I-treatment
; 128 129 128 129 O
or 130 132 130 132 O
2 133 134 133 134 O
) 134 135 134 135 O
has 136 139 136 139 O
not 140 143 140 143 O
been 144 148 144 148 O
naturally 149 158 149 158 O
postmenopausal 159 173 159 173 O
for 174 177 174 177 O
at 178 180 178 180 O
least 181 186 181 186 O
24 187 189 187 189 O
consecutive 190 201 190 201 O
months 202 208 202 208 O
( 209 210 209 210 O
i.e. 210 214 210 214 O
, 214 215 214 215 O
has 216 219 216 219 O
had 220 223 220 223 O
menses 224 230 224 230 O
at 231 233 231 233 O
any 234 237 234 237 O
time 238 242 238 242 O
in 243 245 243 245 O
the 246 249 246 249 O
preceding 250 259 250 259 O
24 260 262 260 262 O
consecutive 263 274 263 274 O
months 275 281 275 281 O
) 281 282 281 282 O

Absolute 0 8 283 291 B-clinical_variable
neutrophil 9 19 292 302 I-clinical_variable
count 20 25 303 308 I-clinical_variable
( 26 27 309 310 I-clinical_variable
ANC 27 30 310 313 I-clinical_variable
) 30 31 313 314 I-clinical_variable
> 32 33 315 316 O
= 33 34 316 317 O
1000 35 39 318 322 B-lower_bound
/ 39 40 322 323 I-lower_bound
mm^3 40 44 323 327 I-lower_bound

All 0 3 328 331 O
study 4 9 332 337 O
participants 10 22 338 350 O
must 23 27 351 355 O
be 28 30 356 358 O
registered 31 41 359 369 O
into 42 46 370 374 O
the 47 50 375 378 O
mandatory 51 60 379 388 O
pomalidomide 61 73 389 401 B-treatment
( 74 75 402 403 I-treatment
POMALYST 75 83 403 411 I-treatment
) 83 84 411 412 I-treatment
Risk 85 89 413 417 O
Evaluation 90 100 418 428 O
and 101 104 429 432 O
Mitigation 105 115 433 443 O
Strategy 116 124 444 452 O
( 125 126 453 454 O
REMS 126 130 454 458 O
) 130 131 458 459 O
program 132 139 460 467 O
, 139 140 467 468 O
and 141 144 469 472 O
be 145 147 473 475 O
willing 148 155 476 483 O
and 156 159 484 487 O
able 160 164 488 492 O
to 165 167 493 495 O
comply 168 174 496 502 O
with 175 179 503 507 O
the 180 183 508 511 O
requirements 184 196 512 524 O
of 197 199 525 527 O
the 200 203 528 531 O
POMALYST 204 212 532 540 O
REMS 213 217 541 545 O
program 218 225 546 553 O

Any 0 3 554 557 O
serious 4 11 558 565 O
medical 12 19 566 573 B-chronic_disease
or 20 22 574 576 O
psychiatric 23 34 577 588 B-chronic_disease
illness 35 42 589 596 I-chronic_disease
that 43 47 597 601 O
could 48 53 602 607 O
, 53 54 607 608 O
in 55 57 609 611 O
the 58 61 612 615 O
investigator 62 74 616 628 O
's 74 76 628 630 O
opinion 77 84 631 638 O
, 84 85 638 639 O
potentially 86 97 640 651 O
interfere 98 107 652 661 O
with 108 112 662 666 O
the 113 116 667 670 O
completion 117 127 671 681 O
of 128 130 682 684 O
treatment 131 140 685 694 B-treatment
according 141 150 695 704 O
to 151 153 705 707 O
this 154 158 708 712 O
protocol 159 167 713 721 O

Calculated 0 10 722 732 B-clinical_variable
creatinine 11 21 733 743 I-clinical_variable
clearance 22 31 744 753 I-clinical_variable
( 32 33 754 755 O
using 33 38 755 760 O
Cockcroft 39 48 761 770 O
- 48 49 770 771 O
Gault 49 54 771 776 O
equation 55 63 777 785 O
) 63 64 785 786 O
> 65 66 787 788 O
= 66 67 788 789 O
30 68 70 790 792 B-lower_bound
mL 71 73 793 795 I-lower_bound
/ 73 74 795 796 I-lower_bound
min 74 77 796 799 I-lower_bound

Corrected 0 9 800 809 O
QT 10 12 810 812 B-clinical_variable
Interval 13 21 813 821 I-clinical_variable
( 22 23 822 823 I-clinical_variable
QTc 23 26 823 826 I-clinical_variable
) 26 27 826 827 I-clinical_variable
> 28 29 828 829 O
470 30 33 830 833 B-lower_bound
milliseconds 34 46 834 846 I-lower_bound
( 47 48 847 848 I-lower_bound
msec 48 52 848 852 I-lower_bound
) 52 53 852 853 I-lower_bound
on 54 56 854 856 O
a 57 58 857 858 O
12 59 61 859 861 B-treatment
- 61 62 861 862 I-treatment
lead 62 66 862 866 I-treatment
ECG 67 70 867 870 I-treatment
obtained 71 79 871 879 O
during 80 86 880 886 O
the 87 90 887 890 O
screening 91 100 891 900 O
period 101 107 901 907 O

Diarrhea 0 8 908 916 B-clinical_variable
> 9 10 917 918 O
grade 11 16 919 924 B-lower_bound
1 17 18 925 926 I-lower_bound
, 18 19 926 927 O
based 20 25 928 933 O
on 26 28 934 936 O
the 29 32 937 940 O
National 33 41 941 949 O
Cancer 42 48 950 956 O
Institute 49 58 957 966 O
Common 59 65 967 973 O
Terminology 66 77 974 985 O
Criteria 78 86 986 994 O
for 87 90 995 998 O
Adverse 91 98 999 1006 O
Events 99 105 1007 1013 O
( 106 107 1014 1015 O
NCI 107 110 1015 1018 O
CTCAE 111 116 1019 1024 O
) 116 117 1024 1025 O
grading 118 125 1026 1033 O
, 125 126 1033 1034 O
in 127 129 1035 1037 O
the 130 133 1038 1041 O
absence 134 141 1042 1049 O
of 142 144 1050 1052 O
antidiarrheals 145 159 1053 1067 B-treatment

EXCEPTIONS 0 10 1068 1078 O
: 10 11 1078 1079 O
Non 12 15 1080 1083 B-cancer
- 15 16 1083 1084 I-cancer
melanoma 16 24 1084 1092 I-cancer
skin 25 29 1093 1097 I-cancer
cancer 30 36 1098 1104 I-cancer
, 36 37 1104 1105 O
ductal 38 44 1106 1112 B-cancer
breast 45 51 1113 1119 I-cancer
carcinoma 52 61 1120 1129 I-cancer
in 62 64 1130 1132 I-cancer
situ 65 69 1133 1137 I-cancer
( 70 71 1138 1139 I-cancer
DCIS 71 75 1139 1143 I-cancer
) 75 76 1143 1144 I-cancer
or 77 79 1145 1147 O
carcinoma 80 89 1148 1157 O
- 89 90 1157 1158 O
in 90 92 1158 1160 O
- 92 93 1160 1161 O
situ 93 97 1161 1165 O
of 98 100 1166 1168 O
the 101 104 1169 1172 O
cervix 105 111 1173 1179 O

Eastern 0 7 1180 1187 B-clinical_variable
Cooperative 8 19 1188 1199 I-clinical_variable
Oncology 20 28 1200 1208 I-clinical_variable
Group 29 34 1209 1214 I-clinical_variable
( 35 36 1215 1216 I-clinical_variable
ECOG 36 40 1216 1220 I-clinical_variable
) 40 41 1220 1221 I-clinical_variable
performance 42 53 1222 1233 I-clinical_variable
status 54 60 1234 1240 I-clinical_variable
( 61 62 1241 1242 I-clinical_variable
PS 62 64 1242 1244 I-clinical_variable
) 64 65 1244 1245 I-clinical_variable
0 66 67 1246 1247 B-lower_bound
, 67 68 1247 1248 O
1 69 70 1249 1250 O
or 71 73 1251 1253 O
2 74 75 1254 1255 B-upper_bound

Evidence 0 8 1256 1264 O
of 9 11 1265 1267 O
current 12 19 1268 1275 O
uncontrolled 20 32 1276 1288 O
cardiovascular 33 47 1289 1303 B-chronic_disease
conditions 48 58 1304 1314 I-chronic_disease
, 58 59 1314 1315 O
including 60 69 1316 1325 O
cardiac 70 77 1326 1333 B-chronic_disease
arrhythmias 78 89 1334 1345 I-chronic_disease
, 89 90 1345 1346 O
congestive 91 101 1347 1357 B-chronic_disease
heart 102 107 1358 1363 I-chronic_disease
failure 108 115 1364 1371 I-chronic_disease
, 115 116 1371 1372 O
angina 117 123 1373 1379 B-chronic_disease
, 123 124 1379 1380 O
or 125 127 1381 1383 O
myocardial 128 138 1384 1394 B-chronic_disease
infarction 139 149 1395 1405 I-chronic_disease
within 150 156 1406 1412 O
the 157 160 1413 1416 O
past 161 165 1417 1421 B-upper_bound
6 166 167 1422 1423 I-upper_bound
months 168 174 1424 1430 I-upper_bound

Females 0 7 1431 1438 B-gender
of 8 10 1439 1441 O
childbearing 11 23 1442 1454 O
potential 24 33 1455 1464 O
( 34 35 1465 1466 O
FCBP 35 39 1466 1470 O
) 39 40 1470 1471 O
* 40 41 1471 1472 O
must 42 46 1473 1477 O
have 47 51 1478 1482 O
a 52 53 1483 1484 O
negative 54 62 1485 1493 B-pregnancy
serum 63 68 1494 1499 I-pregnancy
pregnancy 69 78 1500 1509 I-pregnancy
test 79 83 1510 1514 O
with 84 88 1515 1519 O
a 89 90 1520 1521 O
sensitivity 91 102 1522 1533 B-clinical_variable
of 103 105 1534 1536 O
at 106 108 1537 1539 O
least 109 114 1540 1545 O
50 115 117 1546 1548 B-lower_bound
mIU 118 121 1549 1552 I-lower_bound
/ 121 122 1552 1553 I-lower_bound
mL 122 124 1553 1555 I-lower_bound
within 125 131 1556 1562 O
10 132 134 1563 1565 B-lower_bound
- 134 135 1565 1566 O
14 135 137 1566 1568 B-upper_bound
days 138 142 1569 1573 I-upper_bound
prior 143 148 1574 1579 I-upper_bound
to 149 151 1580 1582 O
and 152 155 1583 1586 O
again 156 161 1587 1592 O
within 162 168 1593 1599 O
24 169 171 1600 1602 B-upper_bound
hours 172 177 1603 1608 I-upper_bound
prior 178 183 1609 1614 I-upper_bound
to 184 186 1615 1617 O
prescribing 187 198 1618 1629 O
pomalidomide 199 211 1630 1642 O
for 212 215 1643 1646 O
cycle 216 221 1647 1652 O
1 222 223 1653 1654 O
( 224 225 1655 1656 O
prescriptions 225 238 1656 1669 O
must 239 243 1670 1674 O
be 244 246 1675 1677 O
filled 247 253 1678 1684 O
within 254 260 1685 1691 O
7 261 262 1692 1693 B-upper_bound
days 263 267 1694 1698 I-upper_bound
as 268 270 1699 1701 O
required 271 279 1702 1710 O
by 280 282 1711 1713 O
RevAssist 283 292 1714 1723 B-treatment
[ 293 294 1724 1725 I-treatment
lenalidomide 294 306 1725 1737 I-treatment
REMS 307 311 1738 1742 I-treatment
program 312 319 1743 1750 I-treatment
] 319 320 1750 1751 I-treatment
) 320 321 1751 1752 O
, 321 322 1752 1753 O
and 323 326 1754 1757 O
must 327 331 1758 1762 O
either 332 338 1763 1769 O
commit 339 345 1770 1776 B-contraception_consent
to 346 348 1777 1779 I-contraception_consent
continued 349 358 1780 1789 I-contraception_consent
abstinence 359 369 1790 1800 I-contraception_consent
from 370 374 1801 1805 I-contraception_consent
heterosexual 375 387 1806 1818 I-contraception_consent
intercourse 388 399 1819 1830 I-contraception_consent
or 400 402 1831 1833 O
begin 403 408 1834 1839 B-contraception_consent
TWO 409 412 1840 1843 I-contraception_consent
acceptable 413 423 1844 1854 I-contraception_consent
methods 424 431 1855 1862 I-contraception_consent
of 432 434 1863 1865 I-contraception_consent
birth 435 440 1866 1871 I-contraception_consent
control 441 448 1872 1879 I-contraception_consent
, 448 449 1879 1880 O
one 450 453 1881 1884 O
highly 454 460 1885 1891 O
effective 461 470 1892 1901 O
method 471 477 1902 1908 O
and 478 481 1909 1912 O
one 482 485 1913 1916 O
additional 486 496 1917 1927 O
effective 497 506 1928 1937 O
method 507 513 1938 1944 O

For 0 3 1945 1948 O
patients 4 12 1949 1957 O
with 13 17 1958 1962 O
extramedullary 18 32 1963 1977 B-chronic_disease
disease 33 40 1978 1985 I-chronic_disease
( 41 42 1986 1987 I-chronic_disease
EMD 42 45 1987 1990 I-chronic_disease
) 45 46 1990 1991 I-chronic_disease
measurable 47 57 1992 2002 O
disease 58 65 2003 2010 O
by 66 68 2011 2013 O
computed 69 77 2014 2022 B-treatment
tomography 78 88 2023 2033 I-treatment
( 89 90 2034 2035 I-treatment
CT 90 92 2035 2037 I-treatment
) 92 93 2037 2038 I-treatment
or 94 96 2039 2041 O
magnetic 97 105 2042 2050 B-treatment
resonance 106 115 2051 2060 I-treatment
imaging 116 123 2061 2068 I-treatment
( 124 125 2069 2070 I-treatment
MRI 125 128 2070 2073 I-treatment
) 128 129 2073 2074 I-treatment
or 130 132 2075 2077 O
the 133 136 2078 2081 O
CT 137 139 2082 2084 O
portion 140 147 2085 2092 O
of 148 150 2093 2095 O
the 151 154 2096 2099 O
positron 155 163 2100 2108 B-treatment
emission 164 172 2109 2117 I-treatment
tomography 173 183 2118 2128 I-treatment
( 184 185 2129 2130 I-treatment
PET)/CT 185 192 2130 2137 I-treatment
: 192 193 2137 2138 O
must 194 198 2139 2143 O
have 199 203 2144 2148 O
at 204 206 2149 2151 O
least 207 212 2152 2157 O
one 213 216 2158 2161 B-lower_bound
lesion 217 223 2162 2168 O
that 224 228 2169 2173 O
has 229 232 2174 2177 O
a 233 234 2178 2179 O
single 235 241 2180 2186 O
diameter 242 250 2187 2195 B-clinical_variable
of 251 253 2196 2198 O
> 254 255 2199 2200 O
= 255 256 2200 2201 O
2 257 258 2202 2203 B-lower_bound
cm 259 261 2204 2206 I-lower_bound
; 261 262 2206 2207 O
skin 263 267 2208 2212 O
lesions 268 275 2213 2220 O
can 276 279 2221 2224 O
be 280 282 2225 2227 O
used 283 287 2228 2232 O
if 288 290 2233 2235 O
the 291 294 2236 2239 O
area 295 299 2240 2244 O
is 300 302 2245 2247 O
> 303 304 2248 2249 O
= 304 305 2249 2250 O
2 306 307 2251 2252 O
cm 308 310 2253 2255 O
in 311 313 2256 2258 O
at 314 316 2259 2261 O
least 317 322 2262 2267 O
one 323 326 2268 2271 O
diameter 327 335 2272 2280 O
and 336 339 2281 2284 O
measured 340 348 2285 2293 O
with 349 353 2294 2298 O
a 354 355 2299 2300 O
ruler 356 361 2301 2306 O

Hemoglobin 0 10 2307 2317 B-clinical_variable
> 11 12 2318 2319 O
= 12 13 2319 2320 O
8.0 14 17 2321 2324 B-lower_bound
g 18 19 2325 2326 I-lower_bound
/ 19 20 2326 2327 I-lower_bound
dL 20 22 2327 2329 I-lower_bound

Known 0 5 2330 2335 O
allergy 6 13 2336 2343 O
to 14 16 2344 2346 O
any 17 20 2347 2350 B-allergy_name
of 21 23 2351 2353 I-allergy_name
the 24 27 2354 2357 I-allergy_name
study 28 33 2358 2363 I-allergy_name
medications 34 45 2364 2375 I-allergy_name
, 45 46 2375 2376 O
their 47 52 2377 2382 O
analogues 53 62 2383 2392 B-allergy_name
or 63 65 2393 2395 I-allergy_name
excipients 66 76 2396 2406 I-allergy_name
in 77 79 2407 2409 I-allergy_name
the 80 83 2410 2413 I-allergy_name
various 84 91 2414 2421 I-allergy_name
formulations 92 104 2422 2434 I-allergy_name

Known 0 5 2435 2440 O
gastrointestinal 6 22 2441 2457 B-chronic_disease
( 23 24 2458 2459 I-chronic_disease
GI 24 26 2459 2461 I-chronic_disease
) 26 27 2461 2462 I-chronic_disease
disease 28 35 2463 2470 I-chronic_disease
or 36 38 2471 2473 O
GI 39 41 2474 2476 B-treatment
procedure 42 51 2477 2486 I-treatment
that 52 56 2487 2491 O
could 57 62 2492 2497 O
interfere 63 72 2498 2507 O
with 73 77 2508 2512 O
the 78 81 2513 2516 O
oral 82 86 2517 2521 O
absorption 87 97 2522 2532 O
or 98 100 2533 2535 O
tolerance 101 110 2536 2545 O
of 111 113 2546 2548 O
ixazomib 114 122 2549 2557 B-treatment
including 123 132 2558 2567 O
difficulty 133 143 2568 2578 O
swallowing 144 154 2579 2589 O

Known 0 5 2590 2595 O
hepatitis 6 15 2596 2605 B-chronic_disease
B 16 17 2606 2607 I-chronic_disease
surface 18 25 2608 2615 O
antigen 26 33 2616 2623 O
- 33 34 2623 2624 O
positive 34 42 2624 2632 O
status 43 49 2633 2639 O
, 49 50 2639 2640 O
or 51 53 2641 2643 O
known 54 59 2644 2649 O
or 60 62 2650 2652 O
suspected 63 72 2653 2662 O
active 73 79 2663 2669 O
hepatitis 80 89 2670 2679 B-chronic_disease
C 90 91 2680 2681 I-chronic_disease
infection 92 101 2682 2691 I-chronic_disease

Known 0 5 2692 2697 O
human 6 11 2698 2703 B-chronic_disease
immunodeficiency 12 28 2704 2720 I-chronic_disease
virus 29 34 2721 2726 I-chronic_disease
( 35 36 2727 2728 I-chronic_disease
HIV 36 39 2728 2731 I-chronic_disease
) 39 40 2731 2732 I-chronic_disease
positive 41 49 2733 2741 O

Major 0 5 2742 2747 B-treatment
surgery 6 13 2748 2755 I-treatment
= 14 15 2756 2757 O
< 15 16 2757 2758 O
14 17 19 2759 2761 B-upper_bound
days 20 24 2762 2766 I-upper_bound
before 25 31 2767 2773 I-upper_bound
study 32 37 2774 2779 O
registration 38 50 2780 2792 O

Men 0 3 2793 2796 B-gender
or 4 6 2797 2799 O
women 7 12 2800 2805 B-gender
of 13 15 2806 2808 O
childbearing 16 28 2809 2821 O
potential 29 38 2822 2831 O
who 39 42 2832 2835 O
are 43 46 2836 2839 O
unwilling 47 56 2840 2849 B-contraception_consent
to 57 59 2850 2852 I-contraception_consent
employ 60 66 2853 2859 I-contraception_consent
adequate 67 75 2860 2868 I-contraception_consent
contraception 76 89 2869 2882 I-contraception_consent

Negative 0 8 2883 2891 B-pregnancy
pregnancy 9 18 2892 2901 I-pregnancy
test 19 23 2902 2906 O
done 24 28 2907 2911 O
= 29 30 2912 2913 O
< 30 31 2913 2914 O
7 32 33 2915 2916 B-upper_bound
days 34 38 2917 2921 I-upper_bound
prior 39 44 2922 2927 I-upper_bound
to 45 47 2928 2930 O
registration 48 60 2931 2943 O
, 60 61 2943 2944 O
for 62 65 2945 2948 O
women 66 71 2949 2954 B-gender
of 72 74 2955 2957 O
childbearing 75 87 2958 2970 O
potential 88 97 2971 2980 O
only 98 102 2981 2985 O

Nursing 0 7 2986 2993 O
women 8 13 2994 2999 B-gender

Other 0 5 3000 3005 O
co 6 8 3006 3008 O
- 8 9 3008 3009 O
morbidity 9 18 3009 3018 O
which 19 24 3019 3024 O
would 25 30 3025 3030 O
interfere 31 40 3031 3040 O
with 41 45 3041 3045 O
patient 46 53 3046 3053 O
's 53 55 3053 3055 O
ability 56 63 3056 3063 O
to 64 66 3064 3066 O
participate 67 78 3067 3078 O
in 79 81 3079 3081 O
trial 82 87 3082 3087 O
, 87 88 3087 3088 O
e.g. 89 93 3089 3093 O
uncontrolled 94 106 3094 3106 B-chronic_disease
infection 107 116 3107 3116 I-chronic_disease
, 116 117 3116 3117 O
uncompensated 118 131 3118 3131 B-chronic_disease
heart 132 137 3132 3137 I-chronic_disease
or 138 140 3138 3140 O
lung 141 145 3141 3145 B-chronic_disease
disease 146 153 3146 3153 I-chronic_disease

Other 0 5 3154 3159 O
concurrent 6 16 3160 3170 O
chemotherapy 17 29 3171 3183 B-treatment
, 29 30 3183 3184 O
radiotherapy 31 43 3185 3197 B-treatment
, 43 44 3197 3198 O
or 45 47 3199 3201 O
any 48 51 3202 3205 O
ancillary 52 61 3206 3215 B-treatment
therapy 62 69 3216 3223 I-treatment
considered 70 80 3224 3234 O
investigational 81 96 3235 3250 O

Other 0 5 3251 3256 O
malignancy 6 16 3257 3267 B-cancer
requiring 17 26 3268 3277 O
active 27 33 3278 3284 O
therapy 34 41 3285 3292 B-treatment

Patient 0 7 3293 3300 O
has 8 11 3301 3304 O
> 12 13 3305 3306 O
= 13 14 3306 3307 O
grade 15 20 3308 3313 B-lower_bound
3 21 22 3314 3315 I-lower_bound
peripheral 23 33 3316 3326 B-chronic_disease
neuropathy 34 44 3327 3337 I-chronic_disease
, 44 45 3337 3338 O
or 46 48 3339 3341 O
grade 49 54 3342 3347 O
2 55 56 3348 3349 O
with 57 61 3350 3354 O
pain 62 66 3355 3359 O
on 67 69 3360 3362 O
clinical 70 78 3363 3371 O
examination 79 90 3372 3383 O
during 91 97 3384 3390 O
the 98 101 3391 3394 O
screening 102 111 3395 3404 O
period 112 118 3405 3411 O

Plasma 0 6 3412 3418 B-clinical_variable
cell 7 11 3419 3423 I-clinical_variable
count 12 17 3424 3429 I-clinical_variable
> 18 19 3430 3431 O
= 19 20 3431 3432 O
0.5 21 24 3433 3436 B-lower_bound
X 25 26 3437 3438 I-lower_bound
10 27 29 3439 3441 I-lower_bound
^ 29 30 3441 3442 I-lower_bound
9 30 31 3442 3443 I-lower_bound
/ 31 32 3443 3444 I-lower_bound
L 32 33 3444 3445 I-lower_bound
or 34 36 3446 3448 O
5 37 38 3449 3450 O
percent 39 46 3451 3458 O
of 47 49 3459 3461 O
the 50 53 3462 3465 O
peripheral 54 64 3466 3476 O
blood 65 70 3477 3482 O
white 71 76 3483 3488 O
cells 77 82 3489 3494 O

Plasma 0 6 3495 3501 B-clinical_variable
cell 7 11 3502 3506 I-clinical_variable
count 12 17 3507 3512 I-clinical_variable
if 18 20 3513 3515 O
determined 21 31 3516 3526 O
by 32 34 3527 3529 O
flow 35 39 3530 3534 B-clinical_variable
cytometry 40 49 3535 3544 I-clinical_variable
, 49 50 3544 3545 O
> 51 52 3546 3547 O
= 52 53 3547 3548 O
200/150,000 54 65 3549 3560 B-lower_bound
events 66 72 3561 3567 O

Platelet 0 8 3568 3576 B-clinical_variable
count 9 14 3577 3582 I-clinical_variable
> 15 16 3583 3584 O
= 16 17 3584 3585 O
50,000 18 24 3586 3592 B-lower_bound
/ 24 25 3592 3593 I-lower_bound
mm^3 25 29 3593 3597 I-lower_bound

Previously 0 10 3598 3608 O
treated 11 18 3609 3616 O
myeloma 19 26 3617 3624 B-cancer
, 26 27 3624 3625 O
currently 28 37 3626 3635 O
with 38 42 3636 3640 O
extramedullary 43 57 3641 3655 B-cancer
disease 58 65 3656 3663 I-cancer
( 66 67 3664 3665 O
defined 67 74 3665 3672 O
as 75 77 3673 3675 O
plasmacytoma 78 90 3676 3688 O
outside 91 98 3689 3696 O
bone 99 103 3697 3701 O
marrow 104 110 3702 3708 O
that 111 115 3709 3713 O
is 116 118 3714 3716 O
not 119 122 3717 3720 O
contiguous 123 133 3721 3731 O
with 134 138 3732 3736 O
a 139 140 3737 3738 O
bone 141 145 3739 3743 O
lesion 146 152 3744 3750 B-clinical_variable
) 152 153 3750 3751 O
with 154 158 3752 3756 O
at 159 161 3757 3759 O
least 162 167 3760 3765 O
one 168 171 3766 3769 O
lesion 172 178 3770 3776 O
that 179 183 3777 3781 O
has 184 187 3782 3785 O
a 188 189 3786 3787 O
single 190 196 3788 3794 O
diameter 197 205 3795 3803 O
of 206 208 3804 3806 O
> 209 210 3807 3808 O
= 210 211 3808 3809 O
2 212 213 3810 3811 B-lower_bound
cm 214 216 3812 3814 I-lower_bound
or 217 219 3815 3817 O
plasma 220 226 3818 3824 B-cancer
cell 227 231 3825 3829 I-cancer
leukemia 232 240 3830 3838 I-cancer
( 241 242 3839 3840 O
defined 242 249 3840 3847 O
as 250 252 3848 3850 O
circulating 253 264 3851 3862 O
plasma 265 271 3863 3869 O
cells 272 277 3870 3875 O
exceeding 278 287 3876 3885 O
5 288 289 3886 3887 B-lower_bound
% 289 290 3887 3888 I-lower_bound
of 291 293 3889 3891 O
peripheral 294 304 3892 3902 B-clinical_variable
blood 305 310 3903 3908 I-clinical_variable
leukocytes 311 321 3909 3919 I-clinical_variable
or 322 324 3920 3922 O
0.5 325 328 3923 3926 B-lower_bound
X 329 330 3927 3928 I-lower_bound
10 331 333 3929 3931 I-lower_bound
^ 333 334 3931 3932 I-lower_bound
9 334 335 3932 3933 I-lower_bound
/ 335 336 3933 3934 I-lower_bound
L 336 337 3934 3935 I-lower_bound
or 338 340 3936 3938 O
200 341 344 3939 3942 B-upper_bound
cells/150000 345 357 3943 3955 I-upper_bound
events 358 364 3956 3962 O
by 365 367 3963 3965 O
flow 368 372 3966 3970 O
cytometry 373 382 3971 3980 O
) 382 383 3980 3981 O

Systemic 0 8 3982 3990 B-treatment
treatment 9 18 3991 4000 I-treatment
with 19 23 4001 4005 I-treatment
strong 24 30 4006 4012 I-treatment
CYP3A4 31 37 4013 4019 I-treatment
inducers 38 46 4020 4028 I-treatment
( 47 48 4029 4030 O
e.g. 48 52 4030 4034 O
rifampin 53 61 4035 4043 B-treatment
, 61 62 4043 4044 O
rifapentine 63 74 4045 4056 B-treatment
, 74 75 4056 4057 O
rifabutin 76 85 4058 4067 B-treatment
, 85 86 4067 4068 O
carbamazepine 87 100 4069 4082 B-treatment
, 100 101 4082 4083 O
phenytoin 102 111 4084 4093 B-treatment
, 111 112 4093 4094 O
phenobarbital 113 126 4095 4108 B-treatment
, 126 127 4108 4109 O
gingko 128 134 4110 4116 B-treatment
biloba 135 141 4117 4123 I-treatment
, 141 142 4123 4124 O
St. 143 146 4125 4128 B-treatment
John 147 151 4129 4133 I-treatment
's 151 153 4133 4135 I-treatment
wort 154 158 4136 4140 I-treatment
) 158 159 4140 4141 O
within 160 166 4142 4148 O
7 167 168 4149 4150 B-upper_bound
days 169 173 4151 4155 I-upper_bound
before 174 180 4156 4162 I-upper_bound
registration 181 193 4163 4175 O

at 0 2 4176 4178 O
least 3 8 4179 4184 O
28 9 11 4185 4187 B-lower_bound
days 12 16 4188 4192 I-lower_bound
before 17 23 4193 4199 O
she 24 27 4200 4203 O
starts 28 34 4204 4210 O
taking 35 41 4211 4217 O
pomalidomide 42 54 4218 4230 B-treatment
FCBP 55 59 4231 4235 O
must 60 64 4236 4240 O
also 65 69 4241 4245 O
agree 70 75 4246 4251 O
to 76 78 4252 4254 O
ongoing 79 86 4255 4262 O
pregnancy 87 96 4263 4272 B-pregnancy
testing 97 104 4273 4280 O
; 104 105 4280 4281 O
men 106 109 4282 4285 B-gender
must 110 114 4286 4290 O
agree 115 120 4291 4296 B-contraception_consent
to 121 123 4297 4299 I-contraception_consent
use 124 127 4300 4303 I-contraception_consent
a 128 129 4304 4305 I-contraception_consent
latex 130 135 4306 4311 I-contraception_consent
condom 136 142 4312 4318 I-contraception_consent
during 143 149 4319 4325 O
sexual 150 156 4326 4332 O
contact 157 164 4333 4340 O
with 165 169 4341 4345 O
a 170 171 4346 4347 O
FCBP 172 176 4348 4352 O
even 177 181 4353 4357 O
if 182 184 4358 4360 O
they 185 189 4361 4365 O
have 190 194 4366 4370 O
had 195 198 4371 4374 O
a 199 200 4375 4376 O
successful 201 211 4377 4387 O
vasectomy 212 221 4388 4397 B-treatment
; 221 222 4397 4398 O
patient 223 230 4399 4406 O
must 231 235 4407 4411 O
follow 236 242 4412 4418 O
pregnancy 243 252 4419 4428 O
testing 253 260 4429 4436 O
requirements 261 273 4437 4449 O
as 274 276 4450 4452 O
outlined 277 285 4453 4461 O
in 286 288 4462 4464 O
the 289 292 4465 4468 O
POMALYST 293 301 4469 4477 B-treatment
REMS 302 306 4478 4482 I-treatment
program 307 314 4483 4490 I-treatment

